Pharmacological versus non-pharmacological antipyretic treatments in febrile critically ill adult patients: A systematic review and meta-analysis

Australian Critical Care

Volumn 24, Issue 1, 2011, Pages 4-17

  Hammond, N E ^a   Boyle, M ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Antipyretics; Critically ill; Fever

Indexed keywords

ANTIPYRETIC AGENT;

ADULT; AGED; COMPARATIVE STUDY; CRITICAL ILLNESS; FEVER; HUMAN; INDUCED HYPOTHERMIA; META ANALYSIS; METHODOLOGY; MIDDLE AGED; MORTALITY; REVIEW; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIPYRETICS; CRITICAL ILLNESS; FEVER; HUMANS; HYPOTHERMIA, INDUCED; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79651475248     PISSN: 10367314     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aucc.2010.11.002     Document Type: Review

References (30)

1. Circiumaru B., Baldock G., Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Med 1999, 25(7):668-673.
2. Kluger M.J., Kozac W., Conn C.A., Leon L.R., Soszynski D. The adaptive value of fever. Infect Dis Clin North Am 1996, 10(1):1-20.
3. Laupland K.B. Fever in the critically ill medical patient. Crit Care Med 2009, 37(7 Suppl.):S273-S278.
4. Hussein A. Thermal disorders. Oh's intensive care manual 2003, 764-765. Butterworth-Heinemann, Edinburgh. 5th ed. A.S. Bersten, N. Soni (Eds.).
5. Passlick-Deetjen J., Bedenbender-Stoll E. Why thermosensing? A primer on thermoregulation. Nephrol Dial Transplant 2005, 20(6):1784-1789.
6. Charkoudian N. Skin blood flow in adult humna thermoregulation, How it works, when it does not, and why. Mayo Clin Proc 2003, 78(5):603-612.
7. Sessler D. Thermoregulatory defence mechanisms. Crit Care Med 2009, 37(7 Suppl.):S203-S210.
8. Polderman K.H. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009, 37(7 Suppl.):S186-S202.
9. Avellaneda C., Gomez A., Martos F., Rubio M., Sarmiento J., de la Cuesta F.S. The effect of a single intravenous dose of metamizol 2g, ketorolac 30mg and propacetamol 1g on haemodynamic parameters and postoperative pain after heart surgey. Euro J Anaesthesiol 2000, 17(2):85-90.
10. Boyle M., Hundy S., Torda T.A. Paracetamol administration is associated with hypotension in the critically ill. Aust Crit Care 1997, 10(4):120-122.
11. Brown G. Acetaminophen-induced hypotension. Heart Lung 1996, 25(2):137-140.
12. Cormio M., Citerio G. Continuous low dose diclofenac sodium infusion to control fever in neurosurgical critical care. Neurocrit Care 2007, 6(2):82-89.
13. Creechan T., Vollman K., Kravutske M.E. Cooling by convection vs cooling by conduction for treatment of fever in critically ill adults. Am J Crit Care 2001, 10(1):52-59.
14. Kiekkas B.P., Brokalaki H., Theodorakopoulou G., Baltopoulos G.I. Physical antipyresis in critically ill adults. Am J Nurs 2008, 108(7):40-50.
15. Poblete B., Romand J.A., Pichard C., Konig C., Suter P.M. Metabolic effects of i.v. propacetamol, metamizol or external cooling in critically ill febrile sedated patients. Br J Anaesth 1997, 78(2):123-127.
16. Thompson H.J., Kirkness C.J., Mitchell P.H. Intensive care unit management of fever following traumatic brain injury. Intensive Crit Care Nurs 2007, 23(2):91-96.
17. Higgins J.P.T., Green S. Cochrane handbook for systematic reviews of interventions. Vol Version 5.0.2: The Cochrane Collaboration 2008, www.cochrane-handbook.org.
18. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5(1):13.
19. Broessner G., Beer R., Lackner P., Helbok R., Fischer M., Pfausler B., et al. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease. Stroke 2009, 40:e657-e665.
20. Diringer M.N. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med 2004, 32(2):559-564.
21. Henker R., Rogers S., Kramer D.J., Kelso L., Kerr M., Sereika S. Comparison of fever treatments in the critically ill: a pilot study. Am J Crit Care 2001, 10(4):276-280.
22. Mayer S.A., Kowalski R.G., Presciutti M., Ostapkovich N.D., McGann E., Fitzsimmons B.-F., et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med 2004, 32(12):2508-2515.
23. Gozzoli V., Schöttker P., Suter P.M., Ricou B. Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling. Arch Intern Med 2001, 161(1):121-123.
24. Gozzoli V., Treggiari M.M., Kleger G.-R., Roux-Lombard P., Fathi M., Pichard C., et al. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med 2004, 30(3):401-407.
25. Price T., McGloin S., Izzard J., Gilchrist M. Cooling strategies for patients with severe cerebral insult in ICU (Part 2). Nurs Crit Care 2003, 8(1):37-45.
26. Schulman C.I., Namias N., Doherty J., Manning R.J., Li P., Alhaddad A., et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect 2005, 6(4):369-375.
27. Cruz P., Garutti I., Diaz S., Fernandez-Quero L. Metamizol versus propacetamol: comparative study of the hemodynamic and antipyretic effects in critically ill patients. Rev Esp Anestesiol Reanim 2002, 49(8):391-396.
28. Watts R., Robertson J., Thomas G. Nursing management of fever in children: a systematic review. Inter J Nurs Pract 2003, 9:S1-S8.
29. Hersch M., Raveh D., Izbicki G. Effect of intravenous propacetamol on blood pressure in febrile critically ill patients. Pharmacotherapy 2008, 28(10):1205-1210.
30. Pesenti A., Riboni A., Basilico E., Grossi E. Antipyretic therapy in ICU patients: evaluation of low dose diclofenac sodium. Intensive Care Med 1986, 12(5):370-373.